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Introduction
According to WHO (WHO guideline,
2021), cervical cancer (CC) is one of the
top causes of death among women.
CC in the world:
• 604 000 new CC cases in 2020
• 342 000 women died in 2020
• WHO: cervical screening by using HPV
DNA
CC in Kazakhstan:
• 2nd leading cause of female cancer
• Around 2000 new cases of CC
annually
• Approx.700 death annually (Igissinov
et al, 2021)
NB! The cause of CC is Human
Papillomavirus (HPV)
Self-sampling is the method of collection
of vaginal and cervical samples for HPV
testing (Yeh et al, 2019).
Key Findings
• SS more coverage of women’s
participation in screening rather than in the
regular cervical cancer screening program
(Ping Teresa Yeh, 2019).
• SS is widely used in countries of Latin
America, Africa, and Asia. There is a
number of surveys in China, Uganda, India,
Nicaragua that have shown a high
acceptability of HPV self-sampling by
women (Jeronimo J et al, 2014).
• SS increases the participation of “hard-
to-reach women” in screening program
(Madzima et al, 2017, p. 598).
• SS Availability, solitude, easy-to-use,
efficiency rise the role of HPV self-
sampling in cervical screening program
(Pimple et al, 2019. Yeh et al, 2018, Torres
et al 2018, Benski et al, 2019).
Feasibility of Self-
sampling method:
1. Ease to use
2. High specificity and
sensitivity (Stanczuk et al,
2016).
3. Increase of screening
coverage (Arbyn et al, 2018).
4. Available in remote areas
and in unequipped medical
centers (Pimple et al, 2019)
5. Privacy to overcome cultural
barriers.
6. Cost-effectiveness (Chao et
al, 2018)
Conclusion
The introduction of self-sampling
method for HPV testing in
Kazakhstan could involve more
women in cervical screening
program and save lives.
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Abstract
A potential for self-sampling Human
Papillomavirus testing to include more
of the female population in low- and
middle- income countries in the cervical
screening program (the example of
Kazakhstan).
Fig.1 Cervical screening in Kazakhstan 
(Aimagambetova et al, 2021)
Methodology
A literature review (Pubmed, Medline).
Inclusion criteria: HPV self-sampling (HPV
SS), LMIC.
Fig 2. HPV is the cause of CC 
Fig 4. LMIC
Fig 3. HPV self-sampling (WHO)
